Diabetes, Vol 34, Issue 2 156-160, Copyright © 1985 by American Diabetes Association

ARTICLES

Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus

R Lanes, B Recker, P Fort and F Lifshitz

Recent studies have suggested a partial block in somatomedin (SM) production or growth hormone (GH) action in IDDM. Twelve well-nourished diabetic children (9 males and 3 females with a mean age of 11.2 +/- 3.3 yr), six with an HbA1c of 7.9-11.2% (group A) and six with an HbA1c of 12.5-15.6% (group B), were studied as follows: the GH response after 100 micrograms of oral clonidine and the SM generation capacity after i.m. administration of 0.2 U/kg/dose of human growth hormone (hGH) for 4 days. Group B diabetic subjects had a significantly higher mean +/- SD GH increase after clonidine than did group A patients (delta of 17.4 +/- 4.9 versus 5.7 +/- 6.0 ng/ml, P less than 0.01); the basal GH of both groups were similar (1.6 +/- 0.7 versus 2.3 +/- 1.4 ng/ml). In contrast, the SM response to hGH was significantly decreased in group B children as compared with those in group A (delta of 0.3 +/- 0.3 versus 1.2 +/- 0.4 U/ml, P less than 0.01). The basal SM levels of both groups were normal for age. GH and SM correlated with HbA1c levels (r = +0.80, P less than 0.01; r = -0.79, P less than 0.01, respectively); there was no correlation with plasma and urine glucose or serum cholesterol, cortisol, and transferrin. Our data indicate a blunted SM response to hGH in group B diabetic subjects; this defect in SM generation is apparently not present in group A subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. L. Simpson, N. C. Jackson, F. Shojaee-Moradie, R. H. Jones, D. L. Russell-Jones, P. H. Sonksen, D. B. Dunger, and A. M. Umpleby Insulin-Like Growth Factor I Has a Direct Effect on Glucose and Protein Metabolism, But No Effect on Lipid Metabolism in Type 1 Diabetes J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 425 - 432. [Abstract] [Full Text] [PDF]

				J. Kallio, U. Pesonen, M. K. Karvonen, M. Kojima, H. Hosoda, K. Kangawa, and M. Koulu Enhanced Exercise-Induced GH Secretion in Subjects with Pro7 Substitution in the Prepro-NPY J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5348 - 5352. [Abstract] [Full Text] [PDF]

				N. Attia, S. Caprio, T. W. Jones, R. Heptulla, J. Holcombe, D. Silver, R. S. Sherwin, and W. V. Tamborlane Changes in Free Insulin-Like Growth Factor-1 and Leptin Concentrations during Acute Metabolic Decompensation in Insulin Withdrawn Patients with Type 1 Diabetes J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2324 - 2328. [Abstract] [Full Text]

				S. Jain, D. W. Golde, R. Bailey, and M. E. Geffner Insulin-Like Growth Factor-I Resistance Endocr. Rev., October 1, 1998; 19(5): 625 - 646. [Abstract] [Full Text]

				I. M. Chapman, M. L. Hartman, K. S. Pieper, E. H. Skiles, S. S. Pezzoli, R. L. Hintz, and M. O. Thorner Recovery of Growth Hormone Release from Suppression by Exogenous Insulin-Like Growth Factor I (IGF-I): Evidence for a Suppressive Action of Free Rather Than Bound IGF-I J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2836 - 2842. [Abstract] [Full Text]

				J. Nakae, M. Kato, M. Murashita, N. Shinohara, T. Tajima, and K. Fujieda Long-Term Effect of Recombinant Human Insulin-Like Growth Factor I on Metabolic and Growth Control in a Patient with Leprechaunism J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 542 - 549. [Abstract] [Full Text]

				I. M. Chapman, M. L. Hartman, S. S. Pezzoli, F. E. Harrell Jr., R. L. Hintz, K. G. M. M. Alberti, and M. O. Thorner Effect of Aging on the Sensitivity of Growth Hormone Secretion to Insulin-Like Growth Factor-I Negative Feedback J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2996 - 3004. [Abstract] [Full Text] [PDF]

				D. G. Rogers Puberty and Insulin-Dependent Diabetes Mellitus Clinical Pediatrics, March 1, 1992; 31(3): 168 - 173. [PDF]